Clinical Trial

Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertension

Completed Phase 2
View on ClinicalTrials.gov →
Summary
Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults with Primary Open Angle Glaucoma or Ocular Hypertension
Protocol Amendment History 3 changes
critical Trial completed 2026-07-23
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-05-08
notable Enrollment increased: 228 -> 252 participants 2026-05-08
Trial Details
NCT Number NCT07168902
Lead Sponsor Bausch & Lomb Incorporated
Conditions Glaucoma
Enrollment 252 participants
Start Date 2025-10-24
Primary Completion 2026-05-18 (estimated)
Study Completion 2026-05-18 (estimated)
Updated on ClinicalTrials.gov 2026-07-22